Rchr
J-GLOBAL ID:201201026101361910   Update date: Mar. 04, 2021

Natsuizaka Mitsuteru

Natsuizaka Mitsuteru
Affiliation and department:
Job title: Assistant professor
Research field  (1): Gastroenterology
Research keywords  (3): Hepatocellular carcinoma ,  Esophageal cancer ,  Molecular oncology
Papers (75):
  • Takuya Sho, Goki Suda, Koji Ogawa, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Machiko Umemura, Naoki Kawagishi, Mitsuteru Natsuizaka, et al. Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria. Hepatology research : the official journal of the Japan Society of Hepatology. 2020
  • Taku Shigesawa, Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka, Megumi Kimura, Tomoe Shimazaki, Koji Yamamoto, Ren Yamada, Takashi Kitagataya, Akihisa Nakamura, et al. Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR 1-3 signaling, but not FGFR4 signaling. Carcinogenesis. 2020
  • Taku Shigesawa, Goki Suda, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Ren Yamada, Takashi Kitagataya, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, et al. Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. JGH OPEN. 2020
  • Masatsugu Ohara, Goki Suda, Megumi Kimura, Osamu Maehara, Tomoe Shimazaki, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Naoki Kawagishi, Masato Nakai, et al. Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people. Hepatology research : the official journal of the Japan Society of Hepatology. 2020
  • Takashi Kitagataya, Goki Suda, Kazunori Nagashima, Takehiko Katsurada, Koji Yamamoto, Megumi Kimura, Osamu Maehara, Ren Yamada, Taku Shigesawa, Kazuharu Suzuki, et al. Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan. Journal of gastroenterology and hepatology. 2020
more...
MISC (60):
  • N. Kawagishi, G. Suda, M. Onozawa, M. Kimura, O. Maehara, M. Ohara, T. Izumi, M. Umemura, J. Ito, M. Nakai, et al. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C. JOURNAL OF VIRAL HEPATITIS. 2017. 24. 12. 1098-1106
  • Masahiro Yoshioka, Shinya Ohashi, Tomomi Ida, Yukie Nakai, Osamu Kikuchi, Yusuke Amanuma, Junichi Matsubara, Atsushi Yamada, Shin'ichi Miyamoto, Mitsuteru Natsuizaka, et al. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2017. 36
  • Koji Tanaka, Kelly A. Whelan, Naryan L. Rustgi, Prasanna M. Chandramouleeswaran, Seiji Naganuma, Shingo Kagawa, Mitsuteru Natsuizaka, Yoshiaki Kita, Shoji Natsugoe, Que Jianwen, et al. Notch1 regulates epithelial-mesenchymal transition and tumor-initiating capability in esophageal squamous-cell carcinoma. CANCER RESEARCH. 2016. 76
  • 佐藤 史幸, 夏井坂 光輝, 前原 経, 浅野 彩華, 久保田 良政, 出水 孝章, 梅村 真知子, 伊藤 淳, 常松 聖司, 中井 正人, et al. 肝細胞癌におけるKLF5による癌幹細胞制御機構. 肝臓. 2015. 56. Suppl.3. A1002-A1002
  • 吉野 裕紀, 阿保 大介, 作原 祐介, 高橋 文也, 曽山 武士, 工藤 與亮, 柿坂 達彦, 横尾 英樹, 神山 俊哉, 小川 浩司, et al. Sorafenib導入後HCC症例に対する経動脈治療の検討. IVR: Interventional Radiology. 2015. 30. 3. 273-273
more...
Education (2):
  • 2003 - 2007 Hokkaido University Gastroenterology
  • 1993 - 1999 Hokkaido University
Professional career (1):
  • M.D., Ph.D.
Work history (9):
  • 2012/06 - 現在 Gastroenterology, Hokkaido University Hospital Assistant professor
  • 2012/04 - 2012/05 Gastroenterology, Hokkaido University Hospital
  • 2008/10 - 2012/03 Gastroenterology, University of Pennsylvania Postdoctoral researcher
  • 2007/04 - 2008/09 Sapporo Hokuyu Hospital
  • 2003/04 - 2007/03 Gastroenterology, Hokkaido University Graduate School of Medicine
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page